[SRNE] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
08-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -31.60%
YoY- -76.78%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 1,103 1,276 84 135 92 114 0 -
PBT 33,244 -7,605 -3,356 -1,241 -445 -445 -232 -
Tax 35,323 2 2 4 2 1 0 -
NP -939 -7,605 -3,356 -1,241 -702 -445 -232 26.22%
Tax Rate -106.25% - - - - - - -
Total Cost 2,042 8,881 3,440 1,376 794 559 232 43.66%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -85.13 -596.00 -4,005.73 -922.81 -765.39 -389.08 0.00 -
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -0.03 -0.27 -0.24 -0.10 -0.07 -0.05 -0.03 0.00%
EPS Diluted -0.03 -0.27 -0.24 -0.10 -0.07 -0.05 -0.03 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.